ClinicalTrials.govpublic full text
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma, nkg2d, cell therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888073
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.